Table of Contents
Research & Development
| Lilly Pays Nektar US$150 M Upfront to Co-Develop Broad Immunological Therapy | Abstract pdf html |
| Natasha Piper |
| AstraZeneca and Takeda Partner on Development of Parkinson’s Candidate | Abstract pdf html |
| Natasha Piper |
Mergers & Acquisitions
| Merck & Co. Acquires German Start-Up Rigontec with Aim of Advancing Immuno-Oncology Success | Abstract pdf html |
| Natasha Piper |
| Rocket Pharmaceuticals Reverse Merges with Inotek Pharmaceuticals to Advance Gene Therapies | Abstract pdf html |
| Natasha Piper |
This work is licensed under a Creative Commons Attribution 3.0 License.